跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
CIMA-AEMPS
/
PEMETREXED PFIZER 25 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION
Approved
STANDARD
PEMETREXED PFIZER 25 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION
Pfizer Europe Ma Eeig
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Feb 3, 2021
Approval ID
dc12946071c901cf
Company
Pfizer Europe Ma Eeig
Type
Standard
Approval Details
Approval Id
dc12946071c901cf
Drug Cima Aemps Name
PEMETREXED PFIZER 25 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION
Register Number
1151057004
Holder Company Name
Pfizer Europe Ma Eeig
Marketing Company Name
Pfizer S.L.
Holder Company Detail Path
/organization/pfizer-europe-ma-eeig
Authorization Date
2021-02-03
Dosage Form
CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN
Dose
25 mg/ml
Route Of Administration
VÍA INTRAVENOSA
Prescription Type
Uso Hospitalario
Commercialized
No
Company Name
Pfizer Europe Ma Eeig
Company Detail Path
/organization/pfizer-europe-ma-eeig
Company Information
Pharmaceutical Company Name
Pfizer Europe MA EEIG
Country Name
United Kingdom
Active Ingredients
PEMETREXED DISODIO HEMIPENTAHIDRATO
27,57 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Feb 3, 2021
Approval ID
dc12946071c901cf
Type
Standard
Back to CIMA-AEMPS Approvals
PEMETREXED PFIZER 25 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION - CIMA-AEMPS Drug Approval Details